Lifeboat Foundation

This is a detailed summary of plasma dilution and at 58:38 the future is explained where they will publish human results from 25 people, then start a company whose first order of business will be phase 3 trials with more people and placebo and hopefully funding. It appears you can pay to have the procedure. The hopeful start is this year in may.

Irina will present her recent findings on plasma dilution, showing that age-reversing effects, such as rejuvenating tissues in mice, can be achieved by.
diluting the blood plasma of old mice: Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin.

Continue reading “Tissue Rejuvenation via Plasma Dilution | Irina Conboy, UC Berkeley” »

Code of the Wild (Documentary) at Hello Tomorrow in Paris.

www.codeofthewild.org to watch the trailer and explore the film.

Continue reading “The Future of Genetic Engineering — George Church” »

Muscle constitutes the largest organ in humans, accounting for 40% of body mass, and it plays an essential role in maintaining life. Muscle tissue is notable for its unique ability for spontaneous regeneration. However, in serious injuries such as those sustained in car accidents or tumor resection which results in a volumetric muscle loss (VML), the muscle’s ability to recover is greatly diminished. Currently, VML treatments comprise surgical interventions with autologous muscle flaps or grafts accompanied by physical therapy. However, surgical procedures often lead to reduced muscular function, and in some cases result in a complete graft failure. Thus, there is a demand for additional therapeutic options to improve muscle loss recovery.

A promising strategy to improve the functional capacity of the damaged muscle is to induce de novo regeneration of skeletal muscle via the integration of transplanted cells. Diverse types of cells, including satellite cells (muscle stem cells), myoblasts, and mesenchymal stem cells, have been used to treat muscle loss. However, invasive muscle biopsies, poor cell availability, and limited long-term maintenance impede clinical translation, where millions to billions of mature cells may be needed to provide therapeutic benefits.

Bonny Lemma. Originally published in the HIR Winter 2019 Issue.

Jennifer Lopez has one more industry to add to her illustrious résumé: molecular biology. In 2016, she was asked to be the executive producer of a new futuristic bio-crime drama for NBC called C.R.I.S.P.R. While that project is a work of science fiction, the CRISPR technology that it is based on is very real.

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is not just a gene editing technique, but also a phenomenon that carries significant implications for the future of biotechnology. Therefore, the interactions between the countless players in this field and the objectives driving them are crucial to understanding of CRISPR and the promise it holds.

Check out this amazing video about Synthetic Biology! (Credit: Vasil Hnãtiuk, Denis Sibilev, and Andrei Myshev)

Chair emeritus, SETI institute — the search for extraterrestrial intelligence.

Dr. Jill Tarter is Chair Emeritus for SETI (Search for Extraterrestrial Intelligence) Research at the SETI Institute, a not-for-profit research organization whose mission is to explore, understand, and explain the origin and nature of life in the universe, and to apply the knowledge gained to inspire and guide present and future generations.

Continue reading “Dr. Jill Tarter — Chair Emeritus — SETI Institute — The Search for Extraterrestrial Intelligence” »

Is a postdoctoral scholar at Tufts University, where she conducts research in their Human Robot Interaction Lab (https://hrilab.tufts.edu/).

With a background in psychology and the social sciences, Dr. Chita-Tegmark is interested in topics at the intersection of technology and psychology, such as using artificial social agents in healthcare and the impact of such emerging technologies on human social interactions and well-being.

Continue reading “Dr. Mihaela Chita-Tegmark — Human Robot Interaction Lab, Tufts U — Co-Founder, Future of Life Inst” »

Richard Feynman, one of the most respected physicists of the twentieth century, said “What I cannot create, I do not understand.” Not surprisingly, many physicists and mathematicians have observed fundamental biological processes with the aim of precisely identifying the minimum ingredients that could generate them. One such example are the patterns of nature observed by Alan Turing. The brilliant English mathematician demonstrated in 1952 that it was possible to explain how a completely homogeneous tissue could be used to create a complex embryo, and he did so using one of the simplest, most elegant mathematical models ever written. One of the results of such models is that the symmetry shown by a cell or a tissue can break under a set of conditions.

An anthropologist dives into the world of genetic engineering to explore whether gene-editing tools such as CRISPR fulfill the hope of redesigning our species for the better.

The Mutant Project: Inside the Global Race to Genetically Modify Humans by Eben Kirksey. St. Martin’s Press, November 2020. Excerpt previously published by Black Inc.

Continue reading “The Dawn of CRISPR Mutants” »